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Abstract Background: Oxidized zirconium (OxZr) femo-
ral component for total knee arthroplasty (TKA) have been
introduced in an attempt to reduce polyethylene wear and
secondary osteolysis and improve longevity of implants.
Questions/Purposes: We reviewed clinical studies in lit-
erature evaluating OxZr femoral component for TKA.
The aim of this review was to evaluate the clinical
outcome and survival rate of TKA with an OxZr femoral
component. Methods: A review of the existing literature
was undertaken to collect data on the OxZr femoral
component in order to provide a better understanding
of its performance. Of 34 studies published in the liter-
ature, 8 met the eligibility criteria and were included in
the final analysis. Results: Findings indicated that the
mean Knee Society knee score improved in all series
from preoperative to postoperative evaluation. The post-
operative Knee Society knee score reported range from
84 to 95 and mean postoperative Knee Society function-
al score range from 74 to 90. The revision rate with this
implant is low with up to 12.6 years of follow-up, with
three revisions in total. The survival rate ranged from
100–98.7% at 5–7 years to 97.8% at 10 years. Conclu-
sions: Excellent clinical outcome and high survival rate
has been demonstrated for OxZr femoral component in
TKA. No adverse reaction has been described for this
new material.
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Introduction
The total knee arthroplasty (TKA) is one of the most
revolutionary and successful surgical procedures of mod-
ern orthopedics, through which is possible to relieve
pain, restore joint function, and improve quality of life
[1, 16]. However, polyethylene (PE) wear and osteolysis
still remains one of the major causes of failure in long-
term survival of TKA especially in younger, athletically
active patients and in those with suboptimal component
alignment [5, 6, 10].
In order to reduce the aforementioned complication
and improve the longevity of the implants, oxidized
zirconium (OxZr) was introduced as an alternative bear-
ing for femoral components in TKA. Preliminary studies
in vitro have indicated excellent mechanical properties
for this material with a high resistance to roughening
and a reduction of PE wear when compared to cobalt–
chromium (CoCr) femoral component for total knee
replacement [2–4, 18]. However, it is well known that
preclinical laboratory testing of materials has limitations,
sometimes leading to catastrophic failure, and that proof
for all new technologies must come from clinical trials.
The literature contains many studies which have report-
ed clinical results of OxZr femoral component for TKA
[7–9, 11–15, 17].
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The purpose of this study was to summarize the current
data of clinical studies evaluating OxZr femoral component
for TKA. In particular, the first aim of this study was to
evaluate the clinical outcome for TKA with OxZr femoral
component, as defined by the Knee Society score reported in
literature. The secondary purpose was to assess the survi-
vorship and analyze causes of failure of primary TKAs with
a femoral component made of oxidized Zr.
Methods
Using PubMed, Embase, Cochrane, and Medline, a review
of the medical literature in indexed peer-reviewed journals
was done using the following search terms: Boxinium^ or
Bzirconium,^ Bknee,^ and Barthroplasty/ies.^ Articles were
evaluated in full text by at least two independent reviewers,
and their results were cross-checked by an independent
reviewer who was blind regarding their results and revision
rates. Studies were included if they contained Brevision for
any cause^ or Bclinical results,^ or Bsurvival rate.^ We
excluded in vitro studies, retrieval analysis, case studies,
and studies that focused solely on a specific reason for the
revision (e.g., re-revision, mechanical failure, infection, or
aseptic loosening).
By the time of the final search of the literature in Sep-
tember 2015, 34 published studies that utilized an OxZr
femoral component for TKA were identified, of which 26
did not meet the inclusion criteria for this review. Therefore,
eight articles were included in the current analysis [7–9, 12–
15, 17] (Table 1).
Seven of eight studies reported clinical results as Knee
Society knee scores and one as WOMAC an SF 12 scores.
All studies reported implant survival data. Implant survival
findings in our analysis were either derived directly from
Kaplan–Meier data or extrapolated from revision data.
Results
An improvement over time in Knee Society knee scores was
noted in all studies reporting this outcome. The mean post-
operative Knee Society knee score was 89.8 (range, 84 to
95) and mean postoperative Knee Society functional score
was 82.16 (range, 74 to 90).
Revision rate for any reason was evaluated from this
analysis. The mean survival rate from 5 to 7 years of follow
up was 99.74%. Only one study reported survival at 10 years
of follow up with 97.8% of survival rate. The only reason for
failure was aseptic loosening. Innocenti et al. [13] reported 2
of 98 cases of revision for aseptic loosening of the femoral
component. Holland et al. [8] reported 1 of 199 cases of
aseptic tibial component loosening.
No complications related to the implant or to the
Oxinium material were reported in all the studies.
Discussion
OxZr femoral component for TKA has shown promising
result in some laboratory analyses with better wear proper-
ties than CoCr when articulating with ultra-high molecular
weight polyethylene. These findings promise a reduction of
PE wear and secondary osteolysis and an improvement in
long-term survival of knee joint arthroplasties. The clinical
performance of OxZr implants was investigated by several
authors documenting excellent survival rate and clinical
outcome. From our analysis, survival rate of TKAwith OxZr
femoral component is 99.74% at 5–7 years with high Knee
Society scores achieved.
However, some limitations were identified and need to
be considered when interpreting these data. First, most of the
studies were a nonrandomized study of selected rather than
consecutive cases with a potential for patient selection bias.
Table 1 Summary of reported clinical results
Author Year Study design Knees
(number)
Follow-up
(years)
Clinical
results
Survival
Laskin [15] 2003 RS (randomized
OxZr vs. CoCr)
73 2 KS 92 100%
FS 74
Innocenti et al. [13] 2010 RS (Ox only) 98 6.2 (5–7) KS 84 89.7%
FS 86
Hui et al. [9] 2011 RCT (OxZr vs.
CoCr bilateral TKA)
40 5 KS 89 100%
Kim et al. [14] 2012 RCT DB (OxZr vs.
CoCr bilateral TKA)
331 7.5 (6–8) KS 95 100%
FS 79
Holland et al. [8] 2013 RS (Ox only) 199 5.2 WOMAC
34.5
99.5%
Hofer et al. [7] 2014 RS (Ox only) 109 5.9 (5–10) KS 92 100%
FS 81
Park et al. [17] 2014 RS (Ox only) 71 5.2 (4.2–7.3) KS 92 100%
FS 90
Innocenti et al. [12] 2014 RS (Ox only) 98 11.3 (10–12.6) KS 84 97.8%
FS 83
KS Knee Society knee score, FS Knee Society functional score, WOMAC The Western Ontario and McMaster Universities Arthritis Index, RS
retrospective series, RCT randomized controlled trial, RCT DB randomized controlled trial, double-blind
HSSJ
Second, a control group was not available in all these studies
for direct comparison, so we could not show that a conven-
tional CoCr femoral component would have the same re-
sults. Finally, the follow-up is of relative short duration.
Most of the studies reported results at 5 years of follow up,
and that is an important end point to detect any unexpected
adverse events related to this new material. However, to
demonstrate the potential clinical benefit of OxZr femoral
component in reducing PE wear and increasing survival of
TKA, more investigations with longer follow up are needed.
Clinical results comprising prospective cohort studies, pro-
spective randomized controlled studies, and registry data showed
no significant differences in patients with conventional CoCr
implants and OxZr implants. Analyses of synovial fluids and
evaluation of amount and size of PE particles showed no differ-
ences between OxZr and CoCr femoral components [9, 14].
In conclusion, OxZr femoral component is promising in
order to reduce PE wear and thus increase survival of TKA
implants. The results of the current review demonstrate safe
use of this new material with no adverse reaction and excel-
lent clinical results and survival rate. Further study with
longer follow up is required to confirm this trend and dem-
onstrated the advantages in using this material for TKA.
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